Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Search of: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF FIRST-LINE ENCORAFENIB PLUS CETUXIMAB WITH OR WITHOUT CHEMOTHERAPY VERSUS STANDARD OF CARE THERAPY WITH A SAFETY LEAD-IN OF ENCORAFENIB AND CETUXIMAB PLUS CHEMOTHERAPY IN PARTICIPANTS WITH METAS - Modify Search

Standard Search

Modify your search using expert search syntax.

Note: The ClinicalTrials.gov search syntax is being updated to match the ClinicalTrials.gov application programming interface (API) search syntax. Documentation and interactive examples of the new syntax can be found on the ClinicalTrials.gov API web site. The current syntax will continue to work, but will not be updated to support new features.
Expert Search
This page last reviewed in January 2020